TRUS - Transrectal Ultrasound Procedure

Transrectal ultrasound (TRUS), also called prostate ultrasound, provides images of the prostate and surrounding tissue and allows the physician to examine the gland for abnormalities (e.g., enlarged prostate (BPH), prostate cancer). TRUS and prostate biopsy can be used to diagnose prostate cancer in patients with an abnormal digital rectal examination or elevated PSA level, to assess prostate volume, to detect inflammation of the prostate (e.g., prostatitis), and to help determine the cause of infertility (e.g., blockages caused by prostatic cysts). Transrectal ultrasound also can be used to deliver and monitor prostate cancer treatments such brachytherapy and cryotherapy.

Envisioneering Medical focuses resources and technology to develop equipment to aid physicians in detection, diagnosis and treatment. The TargetScan 3D imaging and targeted biopsy system offers the first real advance in prostate imaging and biopsy in over a decade. It eases any discomfort of probing during examination, as once it is place, there is no need for repositioning. The system allows a physician to generate a true solid 3D image, manipulate it, and precisely plan and undertake a multi-sample biopsy of a targeted tissue mass in the prostate. Click to learn more about TargetScan 3D or ask your physician today.